These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27987139)

  • 41. The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma.
    Muraoka T; Soh J; Toyooka S; Aoe K; Fujimoto N; Hashida S; Maki Y; Tanaka N; Shien K; Furukawa M; Yamamoto H; Asano H; Tsukuda K; Kishimoto T; Otsuki T; Miyoshi S
    Lung Cancer; 2013 Dec; 82(3):485-90. PubMed ID: 24168922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma.
    Tranchant R; Quetel L; Montagne F; De Wolf J; Meiller C; De Koning L; Le Pimpec-Barthes F; Zucman-Rossi J; Jaurand MC; Jean D
    Lung Cancer; 2018 Dec; 126():15-24. PubMed ID: 30527180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD26-mediated regulation of periostin expression contributes to migration and invasion of malignant pleural mesothelioma cells.
    Komiya E; Ohnuma K; Yamazaki H; Hatano R; Iwata S; Okamoto T; Dang NH; Yamada T; Morimoto C
    Biochem Biophys Res Commun; 2014 May; 447(4):609-15. PubMed ID: 24747072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In Silico Transcriptomic Analysis of Wound-Healing-Associated Genes in Malignant Pleural Mesothelioma.
    Rouka E; Beltsios E; Goundaroulis D; Vavougios GD; Solenov EI; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31212858
    [No Abstract]   [Full Text] [Related]  

  • 45. Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis.
    Bruno R; Alì G; Giannini R; Proietti A; Lucchi M; Chella A; Melfi F; Mussi A; Fontanini G
    Oncotarget; 2017 Jan; 8(2):2758-2770. PubMed ID: 27835874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. POLD1 Is Required for Cell Cycle Progression by Overcoming DNA Damage in Malignant Pleural Mesothelioma.
    Shimizu D; Ishibashi M; Yamada T; Toda Y; Hosogi S; Ashihara E
    Cancer Genomics Proteomics; 2024; 21(2):158-165. PubMed ID: 38423601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma].
    Mei W; Wang XM; Liu RA; Xiong W; Zhang YP
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Apr; 42(4):258-267. PubMed ID: 38677988
    [No Abstract]   [Full Text] [Related]  

  • 48. Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma.
    Xu D; Liang SQ; Yang H; Lüthi U; Riether C; Berezowska S; Marti TM; Hall SRR; Bruggmann R; Kocher GJ; Schmid RA; Peng RW
    Br J Cancer; 2018 Jul; 119(1):65-75. PubMed ID: 29921948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MTA1 promotes metastasis of MPM via suppression of E-cadherin.
    Xu C; Hua F; Chen Y; Huang H; Ye W; Yu Y; Shen Z
    J Exp Clin Cancer Res; 2015 Dec; 34():151. PubMed ID: 26689197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis.
    Plönes T; Fischer M; Höhne K; Sato H; Müller-Quernheim J; Zissel G
    Pathol Oncol Res; 2017 Oct; 23(4):723-730. PubMed ID: 28054314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.
    Meerang M; Bérard K; Felley-Bosco E; Lauk O; Vrugt B; Boss A; Kenkel D; Broggini-Tenzer A; Stahel RA; Arni S; Weder W; Opitz I
    Mol Cancer Ther; 2016 May; 15(5):1095-105. PubMed ID: 26839306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro.
    Borchert S; Wessolly M; Schmeller J; Mairinger E; Kollmeier J; Hager T; Mairinger T; Herold T; Christoph DC; Walter RFH; Eberhardt WEE; Plönes T; Wohlschlaeger J; Aigner C; Schmid KW; Mairinger FD
    BMC Cancer; 2019 Jan; 19(1):108. PubMed ID: 30700254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Wnt2 as a new therapeutic target in malignant pleural mesothelioma.
    Mazieres J; You L; He B; Xu Z; Twogood S; Lee AY; Reguart N; Batra S; Mikami I; Jablons DM
    Int J Cancer; 2005 Nov; 117(2):326-32. PubMed ID: 15900580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcipotriol inhibits proliferation of human keratinocytes by downregulating STAT1 and STAT3 signaling.
    Liang W; Lin Z; Zhang L; Qin X; Zhang Y; Sun L
    J Investig Med; 2017 Feb; 65(2):376-381. PubMed ID: 28130440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells.
    Miao J; Kyoyama H; Liu L; Chan G; Wang Y; Urisman A; Yang YL; Liu S; Xu Z; Bin H; Li H; Jablons DM; You L
    J Cell Mol Med; 2020 Jan; 24(1):1087-1098. PubMed ID: 31755214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma.
    Gee GV; Koestler DC; Christensen BC; Sugarbaker DJ; Ugolini D; Ivaldi GP; Resnick MB; Houseman EA; Kelsey KT; Marsit CJ
    Int J Cancer; 2010 Dec; 127(12):2859-69. PubMed ID: 21351265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Expression of CD24 gene in human malignant pleural mesothelioma and its relationship with prognosis].
    Li B; Zhou CX; Pu YQ; Qiu L; Mei W; Xiong W
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Mar; 41(3):168-176. PubMed ID: 37006141
    [No Abstract]   [Full Text] [Related]  

  • 58. Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma.
    Salman A; Abdel Mageed SS; Fathi D; Elrebehy MA; Abulsoud AI; Elshaer SS; Khidr EG; Al-Noshokaty TM; Khaled R; Rizk NI; Elballal MS; Sayed GA; Abd-Elmawla MA; El Tabaa MM; Mohammed OA; Ashraf A; El-Husseiny AA; Midan HM; El-Dakroury WA; Abdel-Reheim MA; Doghish AS
    Pathol Res Pract; 2023 Dec; 252():154947. PubMed ID: 37977032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesothelioma.
    Mairinger FD; Werner R; Flom E; Schmeller J; Borchert S; Wessolly M; Wohlschlaeger J; Hager T; Mairinger T; Kollmeier J; Christoph DC; Schmid KW; Walter RFH
    Virchows Arch; 2017 Jun; 470(6):627-637. PubMed ID: 28466156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism.
    De Santi C; Melaiu O; Bonotti A; Cascione L; Di Leva G; Foddis R; Cristaudo A; Lucchi M; Mora M; Truini A; Tironi A; Murer B; Boldorini R; Cipollini M; Gemignani F; Gasparini P; Mutti L; Landi S
    Sci Rep; 2017 Jun; 7(1):3140. PubMed ID: 28600498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.